Drug recall · October 14, 2020
Losartan Potassium 100 mg recall
Why: CGMP Deviations: FDA lab confirmed presence of an impurity, N-Methylnitrosobutyric acid (NMBA) in the finished product above the interim acceptable daily intake level per manufacturer
Class II: could cause temporary or reversible health problems; serious harm is remote.
The recall
- Product
Losartan Potassium 100 mg, 30 Tabs bottles, Rx only, Packaged and Distributed By: Direct Rx Dawsonville, GA 30534 NDC 61919-952-30
- Lots / codes
Lot: 27AU1801 Exp. 02/28/2021
- Quantity
- 33 bottles
- Company
- Direct Rx, Dawsonville, GA
- Distribution
- GA
- Initiated
- April 30, 2019 · Voluntary: Firm initiated
- Classified
- October 5, 2020
- Reported
- October 14, 2020
- Ended
- December 4, 2020
- How notified
- Letter
The drug: prices, other makers, shortages
If you have this product
- Check the lot number on your package against the lots above. Only those lots are recalled.
- Don't stop a prescription medicine on your own. Call your pharmacy - they can swap it for an unaffected lot or another maker.
- Felt unwell? Contact your doctor, and report it to FDA MedWatch (1-800-FDA-1088 or fda.gov/medwatch).
- Return or dispose of recalled product as the company or your pharmacy advises.
Questions about this recall
No comments yet. Questions, tips, what worked for you - start the conversation.
Watch Losartan
One email when the price moves, a recall or shortage is posted, or the label changes. Plus the monthly biggest-movers report. Unsubscribe in one click.